Ras and Rho regulation of the cell cycle and oncogenesis

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Aberrant Ras activation is a key driver of oncogenesis.
• Ras signaling pathways are extensively studied, but downstream effectors and their roles in cancer are still evolving.
• Mitogen-stimulated cell cycle control is well understood, yet the precise mechanisms of Ras-induced cell cycle deregulation remain unclear.

Purpose of the Study:

• To review current knowledge on how deregulated Ras activation affects cell cycle regulators.
• To emphasize the role of Rho small GTPases in Ras-mediated cell cycle control.
• To explore cell-type specific differences in Ras signaling's interface with the cell cycle machinery.

Main Methods:

• Literature review of Ras signaling in oncogenesis and cell cycle regulation.
• Focus on alterations in cyclin D1, p21(Cip1), and p27(Kip1) function due to Ras.
• Analysis of the involvement of Rho small GTPases and cell-type specific mechanisms.

Main Results:

• Deregulated Ras signaling alters the function of key cell cycle proteins like cyclin D1, p21(Cip1), and p27(Kip1).
• Rho small GTPases play a significant role in mediating Ras's effects on cell cycle progression.
• Cell-type specific differences exist in how Ras signaling interacts with the cell cycle machinery.

Conclusions:

• Understanding Ras-induced cell cycle deregulation is crucial for cancer therapy.
• Rho GTPases and cell-type specific responses are important considerations in Ras-driven oncogenesis.
• Further research into these mechanisms can reveal novel therapeutic targets for cancers with aberrant Ras activation.